1902 ET - Health insurer Tricare's temporary suspension of payments to Zynex could last as long as a year, Chief Financial Officer Anna Lucsok told investors during an earnings call Tuesday. Tricare makes up about a quarter of Zynex's revenue, and the pause caused it to lower revenue guidance for the year. Zynex said it is unclear what specifically triggered Tricare's pause. Zynex is still in Tricare's network and if Tricare starts paying again, it would be responsible for paying all claims that it has processed during its halt, Lucsok said. Zynex shares fall 19%, to $5.65, after market close. (katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
March 11, 2025 19:03 ET (23:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。